Navin R Mahadevan

12PUBLICATIONS
181CO-AUTHORS
Molecular targetsNeurology and neuromuscular diseasesPredictive and prognostic markersHaematological tumoursGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 08, 2025
Systematic Engineering of TROP2-Targeted CAR T-Cell Therapy Overcomes Resistance Pathways in Solid Tumors.

Elliott J Brea, Simon Baldacci, Neil Savage

|Aug 05, 2025
Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non-Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy.

Simon Baldacci, Elliott J Brea, Francesco Facchinetti

|Jul 24, 2025
Molecular Characterization of NUT Carcinoma: A Report from the NUT Carcinoma Registry.

Justin J Kim, Sara A Walton, Navin R Mahadevan

|Jun 04, 2025
Genetic correlates of malignancy in TFE3-rearranged PEComa: a series of 14 cases.

David J Papke, Igor Odintsov, Navin R Mahadevan

|Aug 23, 2024
Targeting TREX1 Induces Innate Immune Response in Drug-Resistant Small-Cell Lung Cancer.

Takahiko Murayama, Navin R Mahadevan, Catherine B Meador

|Jun 24, 2024
Detecting Small Cell Transformation in Patients with Advanced EGFR Mutant Lung Adenocarcinoma through Epigenomic cfDNA Profiling.

Talal El Zarif, Catherine B Meador, Xintao Qiu

Pageof 2

Frequent Collaborators

8 joint publications

David A Barbie

6 joint publications

Cloud P Paweletz

5 joint publications

Marco Campisi

5 joint publications

Tran C Thai